Subscribe Now Subscribe Today
Research Article
 

Phytochemical and Antituberculosis Activity of Coffea brivipes HIERN Extracts



I.A. Oladosu, A.L. Ogundajo, O.O. Aiyelaagbe and N. Emenyonu
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

The present study seeks to evaluate the medicinal relevance of the Coffea brivipes extracts against some clinically identified strains of Mycobacterium tuberculosis, using standard methods of microbial sensitivity test and phytochemical analysis. The whole plant samples of Coffea brivipes were extracted with absolute ethanol. The ethanol extract of Coffea brivipes HIERN (RUBIACEA) was then macerated with hexane, chloroform and ethyl acetate successively to obtain hexane, chloroform and EtOAc soluble extracts. The extracts were screened for their phytochemical composition and anti-bacterial activities. The phytochemical results depicted the presence of carbohydrate, alkaloids, tanins, sterols, flavonoids, resins and phenols distributed in varying degrees. The antibacterial activity of the extracts against Mycobacterium tuberculosis (MTB 050 and 303) were carried out using the egg enriched Lowenstein-Jansen medium with isoniazid, dihydrostreptomycin, enthanbutol and rifampicin as standard control drugs. The extracts showed different anti-bacterial activities at 10-2 and 10-4 bacteria load. MTB 050 strains showed resistance to rifampicin at both innoculum. Hexane and ethylacetate extracts of C. brivipes at 5 mg mL-1 exhibited good anti-bacterial activities against this rifampicin resistance strain. The result suggest that the hexane and ethylacetate extracts of Coffea brivipes can serve as a good cut for the replacement of rifampicin as an anti-Tb drug.

Services
Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

I.A. Oladosu, A.L. Ogundajo, O.O. Aiyelaagbe and N. Emenyonu, 2011. Phytochemical and Antituberculosis Activity of Coffea brivipes HIERN Extracts. Research Journal of Phytochemistry, 5: 130-135.

URL: https://scialert.net/abstract/?doi=rjphyto.2011.130.135
 
Received: February 25, 2011; Accepted: May 16, 2011; Published: July 02, 2011



INTRODUCTION

Coffea brevipes HIERN, a small tree of about 12 ft tall belong to Rubiaceae family. It is found in the under storey of dark forest of West Africa especially in Nigeria, Ivory Coast, Western Cameroon and Zaire. The fruit is pink in colour when ripe and it is borne on the stem (Burkill, 2000). This plant bear close affinity to C. arabica and C. Canephora var. robusta the most widely studied Coffea genus because of their importance in the production of coffee (Nikhila et al., 2008; Sureshkumar et al., 2010).

No recorded investigation as been carried out on phytochemical screening, isolation and medicinal usage of any parts of C. brevipes. However, some other members of the family that are related to C. brevipes have been explored to some extent especially in relation to their morphological studies (Kufa and Burkhardt, 2011).

Daglia et al. (2007), isolated purine alkaloids: caffine, theobromide and theophyline from C. arabica. The report indicated that the seed and pericarp of C. arabica fruits contained a considerable amount of caffine and small amount of theobromide. Theophylline was also reported in pericarp of the ripened fruit. Alzoreky and Nakahara (2001), reported the antioxidant activity of various extract of C. arabica using the ferrymyglobin/ABTS method. Most of the researches done on the phytochemical screening and medicinal activities of coffea family were focused on the fruits possibly because of its edibility and economy value. There is less or no attention on other parts of the plant like the leaves, stem-bark and root-bark. This makes them a novel area in natural product research.

The common isolated compounds from the Coffea species include: β-carotene, α-carotene (Simkin et al., 2008), nitrogenous alkaloids; Caffeine, trigonelline (Koshiro et al., 2006), hydroxycinnamic, p-coumaric, o-coumaric, 3,4-dimethoxycinnamic, caffeic, ferulic, sinapic and 4-methoxycinnamic acids (Andrade et al., 1998).

The primary causative bacterium of tuberculosis is Mycobacterium tuberclosis. Common tuberculosis affects the lungs known as pulmonary tuberculosis. Tuberculosis can also affect the central nervous system, lymphatic, circulatory, genitourinary systems, bones, joints and even skin. Tuberculosis is a highly contagious disease that is usually transmitted through coughing and sneezing. The epidemiology reports shows that on annual basis, 8 million people become ill with tuberculosis while 2 million people die from the disease worldwide. Tuberculosis was also reported to be the leading cause of death among people with HIV/AIDS (WHO, 2006; Cox, 2004; CDC, 2003; Imam et al., 2010). The emergence of a man-made multi-drugs resistance strain of M. tuberculosis (Nikalje and Mudassar, 2011) also called for development of a better drug(s) or cuts from natural products. Medicinal plants in many indigenous African communities especially in Nigeria, are readily and cheaply available alternative to synthetic drugs. They are of great values to phytochemist because of their medicinal properties.

The present study aimed at investigating the phytochemical constituents and pharmacological effect of C. brivipes extracts on clinically isolated Mycobacterium tuberculosis.

MATERIALS AND METHODS

Plant collection: The C. brevipes plant was collected on 20th January, 2009 from a dry farmland at Lalupon village in Ibadan, Oyo state, Nigeria. The plant was authenticated by Mr. Ugbogu O.A. and Mr. Soyewo L.T. of Plant Taxonomy Department, Forestry Research Institute Ibadan, Nigeria (FRIN). A voucher specimen FHI NO 108450 was deposited at FRIN herbarium.

Plant extraction: The plant was air dried and crushed with mechanical crusher. The grinded material was hermetically sealed in plastic for use. The plant sample (2000 g) was subjected to cold extraction. It was soaked in 99% ethanol for a week. The ethanol extract was then collected and concentrated using rotary evaporator at 35°C to give ethanol residue. The ethanol residue (150 g) was then macerated with n-hexane, chloroform and EtOAc successively. Each of the extracts were collected separately and concentrated to give hexane, chloroform and EtOAc residues respectively using rotary evaporator at 35°C.

Antimycobacterial susceptibility test: This was carried out at the TB Research Laboratory, The Zankli Medical Centre (ZMC), Abuja, Nigeria. The agar dilution method using the egg enriched Lowenstein-Jansen (LJ) medium was used as reported by the International Union Against Tuberculosis LJ Medium, 2007 (Nwachukwu et al., 2009). This was done in a safety cabinet Lamilplus 7. Isoniazid, ethanbutol, dihydrostreptomycin and rifampicin were used as standard control drugs at final drug concentration of 0.2, 2.0, 8.0 and 40.0 μg mL-1, respectively in the LJ. The phytodrugs were screened at 5 mg mL-1. The slopes were stored at 4°C prior to inoculation. Well characterized clinical isolates (MTB 050 and MTB 303) of Mycobacterium tuberculosis which are positive to NO3 reduction, negative catalyst labile tests and shows the presence of serpentinous cords on Zn smear. The isolates obtained from the ZMC were diluted in sterile distilled water to 10-2 and 10-4. This corresponds to 1.0 and 0.5 Mcfarland, respectively. 10 μL of each of the 10-2 and 10-4 innoculum concentrations were inoculated using a micropipette on separate standard drugs, phytodrugs and negative control LJ slant media and incubated for six weeks at 37°C. Inoculated media were checked after 3 days for contamination.

Phytochemical methods: Preliminary phytochemical tests for alkaloids, steroids, tannins, anthraquinone, resins, carbohydrate, glycosides, saponins, phenolics and flavonoids were carried out on the extracts. The methods were based on those reported by Trease and Evans (1989) and Sofowora (1993).

RESULTS AND DISCUSSION

Phytochemical test: The result of phytochemical screening revealed some differences in the constituents of the three extracts tested distributed in varying degrees (Table 1). Results obtained from the qualitative phytochemical tests carried out on the fractionated extracts revealed that the extracts contained a wide array of phytochemicals which include carbohydrate, tannins, flavonoids, alkaloids, sterols, resins and phenols. The absence of glycosides, saponins and anthraquinones was also observed. It is a fact that the phytochemical constituent can help one to speculate on the medicinal value of the stem bark. Flavonoids, Tannins, saponins and alkaloids have been reported to have pronounced physiological effect particularly on the nervous system. The presence of these phytochemicals in the C. brivipes extracts suggests that the plant is pharmacologically active, supporting the claim by traditional healers. The result supported the reported phytochemical components indicating presence of alkaloids and flavonoids in the Coffea genus (Simkin et al., 2008; Koshiro et al., 2006; Andrade et al., 1998). Phytochemical results of each extracts also suggested that carbohydrate, alkaloids, tanins, sterols, flavonoids, resins and phenols can be isolated from C. brivipes plant.

Table 1: Phytochemical screening of the extract of C. brivipes
Image for - Phytochemical and Antituberculosis Activity of Coffea brivipes HIERN Extracts
+: Present; -: Not present

Antimycrobacterial susceptibility test: Table 2 shows that there was no growth of MTB 050 observed against Isoniazid (0.2 μg mL-1), Dihydrostreptomycin (8.0 μg mL-1), Ethanbutol (2.0 μg mL-1), Hexane extract (5 mg mL-1), Ethyl acetate extract (5 mg mL-1) after 6-weeks of incubation. These results suggested that the drugs and extracts are active against the MTB 050 isolate. The MTB 050 was not susceptible (after 6-weeks of incubation) to rifampicin because bacterial colonies growth observed was in the range of 200-500 and 20-100 for 10-2 and 10-4 inoculums concentrations, respectively. The chloroform extract (5 mg mL-1) showed partial activity against MTB 050 because at it was not active at high inoculums concentration.

The results of antimycrobacterial susceptibility screening (Table 3) depicted the following: Hexane extract show activity at 5 mg mL-1 against both MTB 303 at 10-2 and 10-4 innoculum concentrations; chloroform fraction show activity at 5 mg mL-1 against MTB 303 at both innoculum (10-2 and 10-4) while ethylacetate fraction show activity at 5 mg mL-1 against MTB 303 at low innoculum (10-4).

Table 2: Antimycobacterial susceptibility result for MTB 050 of the extract of C. brivipes
Image for - Phytochemical and Antituberculosis Activity of Coffea brivipes HIERN Extracts
-: No growth after 6 weeks incubation at 37°C, +: 1-19 colonies growth after 6 weeks incubation at 37°C, +1: 20-100 colonies growth after 6 weeks incubation at 37°C, +2: 100-200 colonies growth after 6 weeks incubation at 37°C, +3: 200-500 colonies growth after 6 weeks incubation at 37°C, 4+: >500 colonies growth (confluent growth) after 6weeks incubation at 37°C

Table 3: Antimycobacterial susceptibility result for MTB 303 of the extract of C. brivipes
Image for - Phytochemical and Antituberculosis Activity of Coffea brivipes HIERN Extracts
-: No growth after 6 weeks incubation at 37°C ,+: 1-19 colonies growth after 6 weeks incubation at 37°C, +1: 20-100 colonies growth after 6 weeks incubation at 37°C, +2: 100-200 colonies growth after 6 weeks incubation at 37°C, +3: 200-500 colonies growth after 6 weeks incubation at 37°C, 4+: >500 colonies growth (confluent growth) after 6weeks incubation at 37°C

MTB 050 strains show resistance to rifampicin activity at both innoculum whereas hexane and ethylacetate fractions exhibited good bacterialcidal activity at 5 mg mL-1 against this rifampicin resistance strain, which serve as a good replacement for rifampicin as an anti-Tb drug. Other tested standard drugs exhibited good bactericidal activity on the two strains at both innoculum except rifampicin that show no activity on MTB 050 strain at both innoculum.

The result of the phytochemical and antimycrobacterial studies suggested the presence of active anti-Tb agent(s) from C. brivipes plant, a contribution to the development of new pharmaceuticals which can serve as good replacement for the existing Tb-drugs. The presence of these compounds may have accounted for the bacterialcidal activity of the various fractions of C. brivipes extract against Mycobacterium tuberculosis strains. Phenolic compounds, alkaloid and saponins are known to exhibit antibacterial activity and antioxidant activity (Ayoola et al., 2008; Hwang et al., 2001; Claus et al., 1990).

CONCLUSION

The active phyto-compound(s) in this present study can be isolated from various fractions of C. brivipes plant paving way for the discovery of novel drugs to combat the rifampicin resistant mycobacterial strain as indicated. The advantage of the extract of C. brivipes plant over the rifampicin and the possible mode of action calls for further work.

ACKNOWLEDGMENT

The authors wish to thank the management of the Zankli Medical Centre, Abuja for making it possible for us to have access to the facilities at their TB research laboratory. We also wish to thank ISESCO-COMSTECH for given IAO a research grant (No. 3189).

REFERENCES

  1. Burkill, H.M., 2000. Useful Plants of West Tropical Africa Volume 4: Families M-R. 2nd Edn., Royal Botanic Gardens, New York, USA., ISBN-13: 9781900347136, pp: 981


  2. Alzoreky, N. and K. Nakahara, 2001. Antioxidant activity of some edible yemeni plants evaluated by ferrylmyoglobin/ABTS assay. Food Sci. Technol. Res., 7: 141-144.
    CrossRef  |  


  3. Cox, R., 2004. Quantitative relationships for specific growth rates and macromolecular compositions of Mycobacterium tuberculosis, Streptomyces coelicolor A3(2) and Escherichia coli B/r: An integrative theoretical approach. Microbiology, 150: 1413-1426.
    CrossRef  |  Direct Link  |  


  4. WHO, 2006. Global and regional incidence. Tuberculosis Fact Sheet No. 104, WHO. http://www.who.int/mediacentre/factsheets/fs104/en/index.html.


  5. Sofowora, A., 1993. Medicinal Plants and Traditional Medicine in Africa. 2nd Edn., Spectrum Books, Ibadan, Nigeria, ISBN-13: 9789782462190, Pages: 289


  6. Trease, G.E. and W.C. Evans, 1989. Pharmacognosy. 13th Edn., Bailliene Tindall, London, pp: 176-180


  7. Ayoola, G.A., H.A. Coker, S.A. Adesegun, A.A. Adepoju-Bello, K. Obaweya, E.C. Ezennia and T.O. Atangbayila, 2008. Phytochemical screening and antioxidant activities of some selected medicinal plants used for malaria therapy in Southwestern Nigeria. Trop. J. Pharm. Res., 7: 1019-1024.
    CrossRef  |  Direct Link  |  


  8. Hwang, E., B.T. Ahn, H.B. Lee, Y.K. Kim and K.S. Lee et al., 2001. Inhibitory activity for chitin synthase II from Saccharomyces cerevisae by tannins and related compounds. Planta Med., 67: 501-504.
    PubMed  |  Direct Link  |  


  9. Claus, E.P., V.E. Tyler and L.R. Brady, 1990. Pharmacognosy. 6th Edn., Henry Kimpton Publishers, London, pp: 79-137


  10. Nikhila, K.R., V.B. Sureshkumar, K.V. Mohanan and A. Santaram, 2008. Association of agronomic characters in robusta coffee (Coffea canephora Pierre ex Froehner). Int. J. Plant Breed. Genet., 2: 47-50.
    CrossRef  |  Direct Link  |  


  11. Sureshkumar, V.B., N.S. Prakash and K.V. Mohanan, 2010. A study of Coffea racemosa x Coffea canephora var. robusta hybrids in relation to certain critically important characters. Int. J. Plant Breed. Gene., 4: 30-35.
    CrossRef  |  


  12. Kufa, T. and J. Burkhardt, 2011. Stomatal characteristics in Arabica coffee germplasm accessions under contrasting environments at Jimma, Southwestern Ethiopia. Int. J. Bot., 7: 63-72.
    CrossRef  |  


  13. Daglia, M., A. Papetti, P. Grisoli, C. Aceti, V. Spini, C. Dacarro and G. Gazzani, 2007. Isolation, identification and quantification of roasted coffee antibacterial compounds. J. Agric. Food Chem., 55: 10208-10213.
    CrossRef  |  Direct Link  |  


  14. Andrade, P.B., R. Leitao, R.M. Seabra, M.B. Oliveira and M.A. Ferreira, 1998. 3,4-Dimethoxycinnamic acid levels as a tool for differentiation of Coffea canephora var. robusta and Coffea Arabica. Food Chem., 61: 511-514.
    CrossRef  |  


  15. CDC, 2003. Advancing HIV prevention: New strategies for a changing epidemic-United States, 2003. Morb. Mortal. Wkly. Rep., 52: 329-332.
    PubMed  |  


  16. Imam, F., M.K. Anwer, M. Iqbal, S. Alam, K.U. Khayyam and M. Sharma, 2010. Tuberculosis: Brief overview and its shifting paradigm for management in India. Int. J. Pharmacol., 6: 755-783.
    CrossRef  |  Direct Link  |  


  17. Nikalje, A.G. and P. Mudassar, 2011. Multidrug-resistant Mycobacterium tuberculosis: A brief review. Asian J. Biol. Sci., 4: 101-115.
    CrossRef  |  Direct Link  |  


  18. Nwachukwu, N.C., A. Orji, I. Kanu and H.C. Okereke, 2009. Epidemiology of pulmonary tuberculosis in some parts of Abia State, Federal Republic of Nigeria. Asian J. Epidemiol., 2: 13-19.
    CrossRef  |  Direct Link  |  


  19. Simkin, A.J., H. Moreau, M. Kuntz, G. Pagny, C. Lin, S. Tanksley and J. McCarthy, 2008. An investigation of carotenoid biosynthesis in Coffea canephora and Coffea arabica. J. Plant Physiol., 165: 1087-1106.
    PubMed  |  


  20. Koshiro, Y., X.Q. Zheng, M.L. Wang, C. Nagai and H. Ashihara, 2006. Changes in content and biosynthetic activity of caffeine and trigonelline during growth and ripening of Coffea arabica and Coffea canephora fruits. Plant Sci., 171: 242-250.
    CrossRef  |  


©  2022 Science Alert. All Rights Reserved